Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
splenic diseases
MeSH D013158 - splenic diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008206:
Lymphatic diseases
0 Companies
0 Drugs
Success rate
D013158:
Splenic diseases
1 Company
1 Drug
$
Success rate
D006971:
Hypersplenism
0 Companies
0 Drugs
Success rate
D013159:
Splenic infarction
0 Companies
0 Drugs
Success rate
D013160:
Splenic neoplasms
0 Companies
0 Drugs
Success rate
D013161:
Splenic rupture
0 Companies
0 Drugs
Success rate
D014400:
Splenic tuberculosis
0 Companies
0 Drugs
Success rate
D050805:
Wandering spleen
0 Companies
0 Drugs
Success rate
D059446:
Heterotaxy syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
1/1
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Sanofi
Imiglucerase
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use